NCT03850886View on ClinicalTrials.gov

Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

August 7, 2019

Study Completion Date

August 7, 2019

Conditions
Non Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Niacinamide Oral Tablet

Nature's Life Niacinamide 1000 mg

DRUG

Antidiabetic

Metformin or Sulphonylurea

Trial Locations (1)

02

AlZahraa hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03850886 - Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients | Biotech Hunter | Biotech Hunter